Understanding how lipid metabolism affects cartilage health in osteoarthritis
Lipid Metabolism in Articular Cartilage and OA Pathogenesis
This study is looking at how a specific pathway in your body affects the health of cartilage in your joints and how problems with it might lead to osteoarthritis, with the hope of finding new ways to help improve joint health for people with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11113920 on NIH RePORTER |
What this research studies
This research investigates the role of the TGFβ pathway in maintaining the health of articular cartilage and how its dysfunction contributes to osteoarthritis (OA). By using advanced techniques like RNA sequencing and ATAC sequencing, the study aims to identify key factors that regulate lipid metabolism in cartilage cells. The researchers are particularly focused on a transcription factor called NFIA, which influences the expression of genes involved in fatty acid synthesis and oxidation. This work could lead to new therapeutic targets for improving cartilage health in OA patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with osteoarthritis, particularly those experiencing significant cartilage degradation.
Not a fit: Patients without osteoarthritis or those with other unrelated joint conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve cartilage health and slow the progression of osteoarthritis.
How similar studies have performed: Previous research has shown promising results in targeting metabolic pathways for treating osteoarthritis, suggesting that this approach could be effective.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Shen, Jie — Washington University
- Study coordinator: Shen, Jie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.